Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Merck & Co., Inc. (MRK)

92.51   0.62 (0.67%) 06-29 19:04
Open: 92.31 Pre. Close: 91.89
High: 92.98 Low: 91.8875
Volume: 8,383,499 Market Cap: 233,940(M)
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 93.09 - 93.45 93.45 - 93.77
Low: 90.86 - 91.32 91.32 - 91.71
Close: 91.72 - 92.47 92.47 - 93.11

Technical analysis

as of: 2022-06-29 4:55:51 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 111.8     One year: 130.58
Support: Support1: 87.88    Support2: 83.05
Resistance: Resistance1: 95.72    Resistance2: 111.8
Pivot: 88.3
Moving Average: MA(5): 92.78     MA(20): 88.71
MA(100): 84.68     MA(250): 80.82
MACD: MACD(12,26): 0.7     Signal(9): 0
Stochastic oscillator: %K(14,3): 78     %D(3): 85.4
RSI: RSI(14): 59.9
52-week: High: 95.72  Low: 70.88
Average Vol(K): 3-Month: 12,766 (K)  10-Days: 17,401 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ MRK ] has closed below upper band by 20.0%. Bollinger Bands are 104.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 13 days. This is a sign that the current trend might continue.

Headline News

Wed, 29 Jun 2022
4 Reasons Why Investors Should Buy Merck (MRK) Stock Now - Zacks Investment Research

Mon, 27 Jun 2022
Dow Movers: BA, MRK - Nasdaq

Mon, 27 Jun 2022
Do Merck's (NYSE:MRK) Earnings Warrant Your Attention? - Simply Wall St

Fri, 24 Jun 2022
MRK: Merck Discussing Another Drugmaker Buyout -- Buy Or Sell? - StockNews.com

Wed, 22 Jun 2022
Merck (MRK) Stock: Why It Increased 4.03% - Pulse 2.0

Wed, 15 Jun 2022
Where Does Merck & Co., Inc. (MRK) Stock Fall in the Drug Manufacturers - General Field? - InvestorsObserver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers—General
Shares Out. 2,530 (M)
Shares Float 2,520 (M)
% Held by Insiders 0.1 (%)
% Held by Institutions 75.2 (%)
Shares Short 16,980 (K)
Shares Short P.Month 16,860 (K)

Stock Financials

EPS 2.82
EPS Est Next Qtl 0.95
EPS Est This Year 3.86
EPS Est Next Year 4.15
Book Value (p.s.) 14.17
Profit Margin (%) 26.2
Operating Margin (%) 34.4
Return on Assets (ttm) 0
Return on Equity (ttm) 0
Qtrly Rev. Growth 49.5
Gross Profit (p.s.) 14.01
Sales Per Share 21.33
EBITDA (p.s.) 8.52
Qtrly Earnings Growth 35.9
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 32.68
PEG Ratio 1
Price to Book value 6.52
Price to Sales 4.33
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2022-01-06
Ex-Dividend Date 2021-12-13
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.